Notch Therapeutics Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 73

Employees

  • Latest Deal Type
  • M&A

Notch Therapeutics General Information

Description

Developer of a T cell-production platform intended to improve the benefit of cell therapies. The company's induced pluripotent stem cell-based technology platform allows for precision control of Notch signaling, which removes several critical limiting factors in the development of cell therapies, delivering the ability to design and manufacture of a uniform supply of therapeutic T cells enabling healthcare professionals to create stem cells that are specifically engineered to address the underlying biology of complex disease systems.

Contact Information

Website
www.notchtx.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 300-2233 Columbia Street
  • Vancouver, British Columbia V5Y 0M6
  • Canada
+1 (778)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 300-2233 Columbia Street
  • Vancouver, British Columbia V5Y 0M6
  • Canada
+1 (778)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Notch Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 31-Mar-2025 Completed Generating Revenue
6. Later Stage VC (Series B1) 14-Jun-2024 Completed Generating Revenue
5. Early Stage VC (Series A) 10-Feb-2021 Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Seed Round 01-Nov-2019 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator 01-Jan-2017 Completed Startup
To view Notch Therapeutics’s complete valuation and funding history, request access »

Notch Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a T cell-production platform intended to improve the benefit of cell therapies. The company's induced pluri
Biotechnology
Vancouver, Canada
73 As of 2024

Philadelphia, PA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Notch Therapeutics Competitors (2)

One of Notch Therapeutics’s 2 competitors is Century Therapeutics, a Formerly VC-backed company based in Philadelphia, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Century Therapeutics Formerly VC-backed Philadelphia, PA
Fate Therapeutics Formerly VC-backed San Diego, CA
You’re viewing 2 of 2 competitors. Get the full list »

Notch Therapeutics Patents

Notch Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026090747-A1 Engineered allogeneic cells and uses thereof Pending 04-Nov-2024
WO-2026044397-A1 Signaling-enhanced engineered cells and methods of use thereof Pending 28-Aug-2024
WO-2024254693-A1 In vitro-derived t cell populations, methods of generation, and methods of use thereof Inactive 13-Jun-2023
WO-2024254690-A1 Stimulatory antigen particles, methods of production, and methods of use thereof Inactive 13-Jun-2023
AU-2024211048-A1 Method for generating t cell lineage populations from stem/progenitor cells Pending 27-Jan-2023 A61K40/11
To view Notch Therapeutics’s complete patent history, request access »

Notch Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Notch Therapeutics Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Allogene Therapeutics Corporation Minority
Amplitude Ventures Venture Capital Minority
Casdin Capital Venture Capital Minority
Centre for Commercialization of Regenerative Medicine Corporation Minority
Creative Destruction Lab Accelerator/Incubator
You’re viewing 5 of 14 investors. Get the full list »

Notch Therapeutics FAQs

  • Where is Notch Therapeutics headquartered?

    Notch Therapeutics is headquartered in Vancouver, Canada.

  • What is the size of Notch Therapeutics?

    Notch Therapeutics has 73 total employees.

  • What industry is Notch Therapeutics in?

    Notch Therapeutics’s primary industry is Biotechnology.

  • Is Notch Therapeutics a private or public company?

    Notch Therapeutics is a Private company.

  • What is Notch Therapeutics’s current revenue?

    The current revenue for Notch Therapeutics is .

  • How much funding has Notch Therapeutics raised over time?

    Notch Therapeutics has raised $104M.

  • Who are Notch Therapeutics’s investors?

    Allogene Therapeutics, Amplitude Ventures, Casdin Capital, Centre for Commercialization of Regenerative Medicine, and Creative Destruction Lab are 5 of 14 investors who have invested in Notch Therapeutics.

  • Who are Notch Therapeutics’s competitors?

    Century Therapeutics and Fate Therapeutics are competitors of Notch Therapeutics.

  • When was Notch Therapeutics acquired?

    Notch Therapeutics was acquired on 31-Mar-2025.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process